As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the headlines this year and the leading moves they made.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- Baxter (2:11)
- Samsung Biologics (3:39)
- Lotte Biologics (5:01)
- Fujifilm Diosynth Biotechnologies (7:04)
- Lonza (10:42)
- Cambrex (13:10)
- Expansions in peptides, oligonucleotides (15:27)
- Bachem (15:49)
- Agilent Technologies (17:01)
- WuXi STA (17:51)
- CordenPharma (19:01)
- Ajinomoto (20:32)
- Bain’s acquisition of F.I.S. (21:19)
- eureKING (22:32)
- New CDMOs enter the market (23:41)
- Bridgewest Group (23:49)
- SynCrest (24:27)
- NewBiologix (25:20)
- Ascend Gene & Cell Therapies (26:19)
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show